Exact Mass: 546.1867

8)-afzelechin

C30H26O10 (546.1526)

Xanthoaphin

C30H26O10 (546.1526)

Flavonol 3-O-rutinoside

C27H30O12 (546.1737)

Globiflorin 3B1

C30H26O10 (546.1526)

1,5-a-L-Arabinotetraose

C20H34O17 (546.1796)

ERASTIN

C30H31ClN4O4 (546.2034)

Farglitazar

C34H30N2O5 (546.2155)

hypocrellin a

C30H26O10 (546.1526)

D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D003879 - Dermatologic Agents Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4]. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4].

Tryptoquivaline

C29H30N4O7 (546.2114)

PA(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C25H39O11P (546.223)

PA(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Lipoxin A5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0)

C25H39O11P (546.223)

PA(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0), in particular, consists of one chain of one Lipoxin A5 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

GMP-N-epsilon-(N-alpha-acetyl lysine methyl ester) 5'-phosphoramidate

C19H29N7O10P (546.1713)

Gmp-n-epsilon-(n-alpha-acetyl lysine methyl ester) 5-phosphoramidate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Gmp-n-epsilon-(n-alpha-acetyl lysine methyl ester) 5-phosphoramidate can be found in a number of food items such as thistle, wax apple, okra, and hedge mustard, which makes gmp-n-epsilon-(n-alpha-acetyl lysine methyl ester) 5-phosphoramidate a potential biomarker for the consumption of these food products.

Xylotetraose

C20H34O17 (546.1796)

Xylotetraose is a tetrasaccharide comprised of four D-xylose residues connected by beta(1->4) linkages. Xylotetraose is a hydrolysis product of Xylan[1]. Xylan is a polysaccharide made from units of xylose and contains predominantly β-D-xylose units linked as in cellulose[2]. Xylotetraose can be used for enzyme biochemical analysis[1][3][4].

Hypocrellin

C30H26O10 (546.1526)

Hypocrellin is a natural product found in Parastagonospora nodorum with data available. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4]. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4].

MLS000863642

C29H30N4O7 (546.2114)

8)-epicatechin

C30H26O10 (546.1526)

(+)-1,2-Dehydro-2-nortelobine

C34H30N2O5 (546.2155)

8)-catechin

C30H26O10 (546.1526)

6)-fisetinidol

C30H26O10 (546.1526)

Physalin T

C28H34O11 (546.2101)

8)-fisetinidol

C30H26O10 (546.1526)

Paratunamide C

C26H30N2O11 (546.185)

Tf-26Vx

C30H26O10 (546.1526)

Elsinochrome D

C30H26O10 (546.1526)

[3S-(3alpha,5alpha,5aalpha,6alpha,9beta,9aalpha,10S*)]-5,10-bis(Acetyloxy)-5a-[(acetyloxy)methyl]-6-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-4H-3,9a-methano-1-benzoxepin-4-one

C28H34O11 (546.2101)

6,7-Dihydro-6-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[3,2-g]fisetinidol

C30H26O10 (546.1526)

hypocrellin a

C30H26O10 (546.1526)

D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D003879 - Dermatologic Agents Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4]. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4].

3alpha-dihydrocadambine

C27H34N2O10 (546.2213)

1,2-Dehydroapateline

C34H30N2O5 (546.2155)

Phaeosphenone

C30H26O10 (546.1526)

ES-242-6

C32H34O8 (546.2254)

8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]fisetinidol

C30H26O10 (546.1526)

Sinensol H

C35H30O6 (546.2042)

Brachycerine

C27H34N2O10 (546.2213)

Vittarin-E

C32H34O8 (546.2254)

3-O-acetylanthothecanolide

C28H34O11 (546.2101)

4-(2,4-Dihydroxyphenyl)-2-(3,4-dihydroxyphenyl)-3,3,4,4-tetrahydro(2,6)-bis-2H-1-benzopyran3,3,7,8-tetraol

C30H26O10 (546.1526)

8,9-Dihydro-10-(2,4-dihydroxyphenyl)-9-hydroxy-8-(4-hydroxyphenyl)-10H-pyrano[2,3-h]-ent-fisetinidol

C30H26O10 (546.1526)

8)-epiafzelechin

C30H26O10 (546.1526)

Fisetinidol-(4alpha-

C30H26O10 (546.1526)

6,7-Dihydro-6-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[3,2-g]-ent-epifisetnidol

C30H26O10 (546.1526)

8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]-ent-epifisetinidol

C30H26O10 (546.1526)

3beta-Isodihydrocadambine

C27H34N2O10 (546.2213)

Gaudispirolactone

C32H34O8 (546.2254)

7-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-3-[4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphenyl]chromen-4-one

C27H30O12 (546.1737)

Acacetin 7-rutinoside

C27H30O12 (546.1737)

Butiniflavan-(4beta->8)-epicatechin

C30H26O10 (546.1526)

(2E)-2,3-didehydro-3-deoxy-maytansinol|(3E,5E,7R,84S,12E)-14-chloro-10t,11c-epoxy-84-hydroxy-15,7r-dimethoxy-3,9c,11t,15-tetramethyl-(84rH,86cH)-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5,12-triene-82,14-dione|Maysin|Maysin (5)|maysine

C28H35ClN2O7 (546.2133)

2-Demethylsteffimycin D

C27H30O12 (546.1737)

Epiguibourtinidol-(4alpha->8)-epicatechin

C30H26O10 (546.1526)

Chaetochromin

C30H26O10 (546.1526)

ent-Epifisetinidol-(4alpha->6)-fisetinidol

C30H26O10 (546.1526)

Fisetinidol-(4alpha->8)-fisetinidol

C30H26O10 (546.1526)

C30H26O10

C30H26O10 (546.1526)

citrusin

C28H34O11 (546.2101)

Fisetinidol-(4beta->6)-fisetinidol

C30H26O10 (546.1526)

3,4-Dihydroxyrottlerin

C31H30O9 (546.189)

Lehmbachol A

C31H30O9 (546.189)

leucomentin-2

C30H26O10 (546.1526)

spiromentins G and H

C30H26O10 (546.1526)

DEHYDROBRUCEANTIN

C28H34O11 (546.2101)

erythro-1-(4-hydroxy-3-methoxyphenyl)-2-<4-(3-hydroxypropyl)-2-methoxyphenoxy>propane-1,3-diol tetraacetate|threo-1-(4-hydroxy-3-methoxyphenyl)-2-<4-(3-hydroxypropyl)-2-methoxyphenoxy>propane-1,3-diol tetraacetate

C28H34O11 (546.2101)

3beta-Isodihydrocadambin

C27H34N2O10 (546.2213)

Benzyl glycoside,6-O-benzylidene,2-Ac-beta-Pyranose-3-O-alpha-L-Rhamnopyranosyl-D-galactose

C28H34O11 (546.2101)

Pyrano[4,3:4,5]azepino[1,2:1,2]pyrido[3,4-b]indole-1-carboxylic acid, 4-(beta-D-glucopyranosyloxy)-4,4a,5,6,8,9,14,14b,15,15a-decahydro-5-hydroxy-, methyl ester, (4S,4aS,5S,14bS,15aS)-

C27H34N2O10 (546.2213)

(4beta,6)-bis-(-)-fisetinidol

C30H26O10 (546.1526)

lysidicin H

C28H34O11 (546.2101)

(1R,2S,4R,5S,6R,7R,9S,10S)-9-benzoyloxy-1-hydroxy-2,6,15-triacetoxy-8-oxo-dihydro-beta-agarofuran

C28H34O11 (546.2101)

Elsinochrome B

C30H26O10 (546.1526)

Dihydrocadambin

C27H34N2O10 (546.2213)

kadsuphilin A

C32H34O8 (546.2254)

C32H34O8

C32H34O8 (546.2254)

Esmeraldic acid dimethyl ester

C32H26N4O5 (546.1903)

spiromentins I/J

C30H26O10 (546.1526)

O-alpha-L-Arabinofuranosyl-(1->3)-O-4)>-O-beta-D-xylopyranosyl-(1->4)-D-xylose|O-beta-D-xylopyranosyl-(1-4)-O-(alpha-L-arabinofuranosyl-(1-3))-O-beta-D-xylopyranosyl-(1-4)-D-xylopyranose|O-beta-D-xylopyranosyl-(1-4)-O--O-beta-D-xylopyranosyl-(1-4)-D-xylopyranose

C20H34O17 (546.1796)

spiromentin E|spiromentin F

C30H26O10 (546.1526)

phomalevone A

C30H26O10 (546.1526)

A biaryl that is 5,5,10a,10a-tetrahydro-9H,9H-2,2-bixanthene-9,9-dione substituted by hydroxy groups at positions 1, 1, 5, 5, 8 and 8 and methyl groups at positions 3, 3, 10a and 10a. Isolated from the cultures of a Hawaiian isolate of the fungus Phoma species, it exhibits antibacterial activity.

Phomalevone B

C30H26O10 (546.1526)

A member of the class of biphenyls that is 6,6-dimethylbiphenyl-2,2,4,4-tetrol which has been substituted by 3,6-dihydroxy-2-methylbenzoyl groups at positions 3 and 3. Isolated from the cultures of a Hawaiian isolate of the fungus Phoma species, it exhibits antibacterial and antifungal activities.

1-O-deacetyl-2alpha-methoxylkhayanolide E|khayseneganin G

C28H34O11 (546.2101)

C24H34O14

C24H34O14 (546.1948)

fisetinidol-(4alpha?6)-gallocatechin

C30H26O10 (546.1526)

chrysin 6-C-(2-O-alpha-L-rhamnosyl)-beta-L-fucopyranoside

C27H30O12 (546.1737)

chrysin 6-C-beta-boivinopyranosyl-7-O-beta-D-glucopyranoside

C27H30O12 (546.1737)

(E)-3,3?-(2-methylpropane-1,1-diyl)-bis(6-((E)-3,4-dihydroxystyryl)-4-hydroxy-2H-pyran-2-one)|phaeolschidin A

C30H26O10 (546.1526)

7-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyl-6,8-dimethoxy-7-hydroxycoumarin|nitensoside B

C23H30O15 (546.1585)

Atrovirin B|atrovirin-B

C30H26O10 (546.1526)

O-alpha-L-Arabinofuranosyl-(1->3)-O-beta-D-xylopyranosyl-(1->4)-O-beta-D-xylopyranosyl-(1->4)-D-xylopyranose

C20H34O17 (546.1796)

(7R,8R,8R)-4-demethyldeoxypodophyllotoxin 4-O-beta-D-glucopyranoside|4-Demethyldesoxypodophyllotoxin 4-O-beta-D-glucoside|4-demethyldesoxypodophyllotoxin beta-D-glucoside|4-demethyldesoxypodophyllotoxin-4-O-beta-D-glucoside|4-Demethyldesoxypodophyllotoxin-4-O-??-D-glucoside

C27H30O12 (546.1737)

1,4-B-D-XYLOTETRAOSE

C20H34O17 (546.1796)

Pigmentosin A

C30H26O10 (546.1526)

4,C4-dihydro-4-hydroxy-8-oxo-beta-agarofuran-1alpha,2alpha,6beta,9alpha-tetrayl 1alpha,2alpha,6beta-triacetate 9alpha-benzoate

C28H34O11 (546.2101)

O-De-Me,tri-Ac-Cycloartocarpin

C31H30O9 (546.189)

C21H38O16

C21H38O16 (546.216)

morellic acid

C32H34O8 (546.2254)

Tri-Ac-Auriculasin

C31H30O9 (546.189)

Elsinochrome C

C30H26O10 (546.1526)

(2S)-1-acetoxy-4t-[2-((S)-1-hydroxy-2-methyl-propyl)-4-oxo-4H-quinazolin-3-yl]-2,2-dimethyl-(2rC8a,9rO,9at)-3,4,1,9a-tetrahydro-2H-spiro[furan-2,9-imidazo[1,2-a]indole]-5,3-dione|Isotryptoquivalin|Isotryptoquivaline|Tryptoquivalin C

C29H30N4O7 (546.2114)

Fisetinidol-(4alpha->8)-afzelechin

C30H26O10 (546.1526)

bistartamide E|bistratamide E

C25H34N6O4S2 (546.2083)

Anthracycline XF 1

C27H30O12 (546.1737)

cinnamrutinose B

C28H34O11 (546.2101)

(-)-cappadoside

C27H30O12 (546.1737)

7-O-(5-phenyl-2,4-pentadienoyl)-8-epiloganin

C28H34O11 (546.2101)

6-(3,7-dihydro xychroman-2-yl)-4-(2,4-dihydroxyphenyl)-3,3,4,8-tetrahydro xyflavan

C30H26O10 (546.1526)

Flavomannin

C30H26O10 (546.1526)

NSC655651

C32H34O8 (546.2254)

His Phe Glu Asp

C24H30N6O9 (546.2074)

Phe Glu His Asp

C24H30N6O9 (546.2074)

7-(5-formyl-3,6-dihydroxy-7-methoxy-1-methyl-8-propan-2-ylnaphthalen-2-yl)-2,8-dihydroxy-3-methoxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde

C32H34O8 (546.2254)

N, N, N-Di-p-hydroxybenxoyl, feruloylagmatine

C29H30N4O7 (546.2114)

Bepotastine Besilate

C27H31ClN2O6S (546.1591)

C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Bepotastine besilate is a selective and orally active second-generation histamine H1 receptor antagonist, can suppress the expression of nerve growth factor (NGF). Bepotastine besilate has the potential for allergic rhinitis, allergic conjunctivitis and urticaria/pruritus research[1][2][3][4].

Cymoside - CASMI2016 Category 1 - Challenge 5

C27H34N2O10 (546.2213)

7-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-3-[4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphenyl]chromen-4-one

C27H30O12 (546.1737)

1,3,4-trihydroxy-5-[(E)-3-[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoyl]oxycyclohexane-1-carboxylic acid

C27H30O12 (546.1737)

Afzelechin-(4a->8)-afzelechin

C30H26O10 (546.1526)

C27H35ClN4O6_2(6H)-Isoquinolineacetic acid, 7-(acetyloxy)-alpha-[3-[(aminoiminomethyl)amino]propyl]-5-chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7,8-dihydro-7-methyl-6,8-dioxo

C27H35ClN4O6 (546.2245)

C27H30O12_Cyclohexanecarboxylic acid, 3-[[(2E)-3-[2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-5-benzofuranyl]-1-oxo-2-propen-1-yl]oxy]-1,4,5-trihydroxy

C27H30O12 (546.1737)

Farglitazar

C34H30N2O5 (546.2155)

CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5746; ORIGINAL_PRECURSOR_SCAN_NO 5743 C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5760; ORIGINAL_PRECURSOR_SCAN_NO 5756 CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5717; ORIGINAL_PRECURSOR_SCAN_NO 5714 CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5752; ORIGINAL_PRECURSOR_SCAN_NO 5748 CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5751; ORIGINAL_PRECURSOR_SCAN_NO 5750 CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5754; ORIGINAL_PRECURSOR_SCAN_NO 5753 CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10453; ORIGINAL_PRECURSOR_SCAN_NO 10449 CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10505; ORIGINAL_PRECURSOR_SCAN_NO 10503 CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10516; ORIGINAL_PRECURSOR_SCAN_NO 10511 CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10552; ORIGINAL_PRECURSOR_SCAN_NO 10548 CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10569; ORIGINAL_PRECURSOR_SCAN_NO 10567 CONFIDENCE standard compound; INTERNAL_ID 508; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10577; ORIGINAL_PRECURSOR_SCAN_NO 10575

Ala Met Tyr Tyr

C26H34N4O7S (546.2148)

Ala Tyr Met Tyr

C26H34N4O7S (546.2148)

Ala Tyr Tyr Met

C26H34N4O7S (546.2148)

Cys Asp Phe Tyr

C25H30N4O8S (546.1784)

Cys Asp Tyr Phe

C25H30N4O8S (546.1784)

Cys Phe Asp Tyr

C25H30N4O8S (546.1784)

Cys Phe Phe Met

C26H34N4O5S2 (546.1971)

Cys Phe Met Phe

C26H34N4O5S2 (546.1971)

Cys Phe Tyr Asp

C25H30N4O8S (546.1784)

Cys Met Phe Phe

C26H34N4O5S2 (546.1971)

Cys Met Met Tyr

C22H34N4O6S3 (546.164)

Cys Met Tyr Met

C22H34N4O6S3 (546.164)

Cys Val Tyr Tyr

C26H34N4O7S (546.2148)

Cys Tyr Asp Phe

C25H30N4O8S (546.1784)

Cys Tyr Phe Asp

C25H30N4O8S (546.1784)

Cys Tyr Met Met

C22H34N4O6S3 (546.164)

Cys Tyr Val Tyr

C26H34N4O7S (546.2148)

Cys Tyr Tyr Val

C26H34N4O7S (546.2148)

Asp Cys Phe Tyr

C25H30N4O8S (546.1784)

Asp Cys Tyr Phe

C25H30N4O8S (546.1784)

Asp Glu Phe His

C24H30N6O9 (546.2074)

Asp Glu His Phe

C24H30N6O9 (546.2074)

Asp Phe Cys Tyr

C25H30N4O8S (546.1784)

Asp Phe Glu His

C24H30N6O9 (546.2074)

Asp Phe His Glu

C24H30N6O9 (546.2074)

Asp Phe Tyr Cys

C25H30N4O8S (546.1784)

Asp His Glu Phe

C24H30N6O9 (546.2074)

Asp His Phe Glu

C24H30N6O9 (546.2074)

Asp Ser Tyr Tyr

C25H30N4O10 (546.1962)

Asp Tyr Cys Phe

C25H30N4O8S (546.1784)

Asp Tyr Phe Cys

C25H30N4O8S (546.1784)

Asp Tyr Ser Tyr

C25H30N4O10 (546.1962)

Asp Tyr Tyr Ser

C25H30N4O10 (546.1962)

Glu Asp Phe His

C24H30N6O9 (546.2074)

Glu Asp His Phe

C24H30N6O9 (546.2074)

Glu Phe Asp His

C24H30N6O9 (546.2074)

Glu Phe His Asp

C24H30N6O9 (546.2074)

Glu His Asp Phe

C24H30N6O9 (546.2074)

Glu His Phe Asp

C24H30N6O9 (546.2074)

Glu His Met Met

C21H34N6O7S2 (546.193)

Glu Met His Met

C21H34N6O7S2 (546.193)

Glu Met Met His

C21H34N6O7S2 (546.193)

Phe Cys Asp Tyr

C25H30N4O8S (546.1784)

Phe Cys Phe Met

C26H34N4O5S2 (546.1971)

Phe Cys Met Phe

C26H34N4O5S2 (546.1971)

Phe Cys Tyr Asp

C25H30N4O8S (546.1784)

Phe Asp Cys Tyr

C25H30N4O8S (546.1784)

Phe Asp Glu His

C24H30N6O9 (546.2074)

Phe Asp His Glu

C24H30N6O9 (546.2074)

Phe Asp Tyr Cys

C25H30N4O8S (546.1784)

Phe Glu Asp His

C24H30N6O9 (546.2074)

Phe Phe Cys Met

C26H34N4O5S2 (546.1971)

Phe Phe Met Cys

C26H34N4O5S2 (546.1971)

Phe His Asp Glu

C24H30N6O9 (546.2074)

Phe His Glu Asp

C24H30N6O9 (546.2074)

Phe Met Cys Phe

C26H34N4O5S2 (546.1971)

Phe Met Phe Cys

C26H34N4O5S2 (546.1971)

Phe Met Ser Tyr

C26H34N4O7S (546.2148)

Phe Met Tyr Ser

C26H34N4O7S (546.2148)

Phe Ser Met Tyr

C26H34N4O7S (546.2148)

Phe Ser Tyr Met

C26H34N4O7S (546.2148)

Phe Tyr Cys Asp

C25H30N4O8S (546.1784)

Phe Tyr Asp Cys

C25H30N4O8S (546.1784)

Phe Tyr Met Ser

C26H34N4O7S (546.2148)

Phe Tyr Ser Met

C26H34N4O7S (546.2148)

His Asp Glu Phe

C24H30N6O9 (546.2074)

His Asp Phe Glu

C24H30N6O9 (546.2074)

His Glu Asp Phe

C24H30N6O9 (546.2074)

His Glu Phe Asp

C24H30N6O9 (546.2074)

His Glu Met Met

C21H34N6O7S2 (546.193)

His Phe Asp Glu

C24H30N6O9 (546.2074)

His Met Glu Met

C21H34N6O7S2 (546.193)

His Met Met Glu

C21H34N6O7S2 (546.193)

His Asn Asn Tyr

C23H30N8O8 (546.2186)

His Asn Tyr Asn

C23H30N8O8 (546.2186)

His Tyr Asn Asn

C23H30N8O8 (546.2186)

Met Ala Tyr Tyr

C26H34N4O7S (546.2148)

Met Cys Phe Phe

C26H34N4O5S2 (546.1971)

Met Cys Met Tyr

C22H34N4O6S3 (546.164)

Met Cys Tyr Met

C22H34N4O6S3 (546.164)

Met Glu His Met

C21H34N6O7S2 (546.193)

Met Glu Met His

C21H34N6O7S2 (546.193)

Met Phe Cys Phe

C26H34N4O5S2 (546.1971)

Met Phe Phe Cys

C26H34N4O5S2 (546.1971)

Met Phe Ser Tyr

C26H34N4O7S (546.2148)

Met Phe Tyr Ser

C26H34N4O7S (546.2148)

Met His Glu Met

C21H34N6O7S2 (546.193)

Met His Met Glu

C21H34N6O7S2 (546.193)

Met Met Cys Tyr

C22H34N4O6S3 (546.164)

Met Met Glu His

C21H34N6O7S2 (546.193)

Met Met His Glu

C21H34N6O7S2 (546.193)

Met Met Tyr Cys

C22H34N4O6S3 (546.164)

Met Ser Phe Tyr

C26H34N4O7S (546.2148)

Met Ser Tyr Phe

C26H34N4O7S (546.2148)

Met Tyr Ala Tyr

C26H34N4O7S (546.2148)

Met Tyr Cys Met

C22H34N4O6S3 (546.164)

Met Tyr Phe Ser

C26H34N4O7S (546.2148)

Met Tyr Met Cys

C22H34N4O6S3 (546.164)

Met Tyr Ser Phe

C26H34N4O7S (546.2148)

Met Tyr Tyr Ala

C26H34N4O7S (546.2148)

Asn His Asn Tyr

C23H30N8O8 (546.2186)

Asn His Tyr Asn

C23H30N8O8 (546.2186)

Asn Asn His Tyr

C23H30N8O8 (546.2186)

Asn Asn Asn Trp

C23H30N8O8 (546.2186)

Asn Asn Trp Asn

C23H30N8O8 (546.2186)

Asn Asn Tyr His

C23H30N8O8 (546.2186)

Asn Trp Asn Asn

C23H30N8O8 (546.2186)

Asn Tyr His Asn

C23H30N8O8 (546.2186)

Asn Tyr Asn His

C23H30N8O8 (546.2186)

Ser Asp Tyr Tyr

C25H30N4O10 (546.1962)

Ser Phe Met Tyr

C26H34N4O7S (546.2148)

Ser Phe Tyr Met

C26H34N4O7S (546.2148)

Ser Met Phe Tyr

C26H34N4O7S (546.2148)

Ser Met Tyr Phe

C26H34N4O7S (546.2148)

Ser Tyr Asp Tyr

C25H30N4O10 (546.1962)

Ser Tyr Phe Met

C26H34N4O7S (546.2148)

Ser Tyr Met Phe

C26H34N4O7S (546.2148)

Ser Tyr Tyr Asp

C25H30N4O10 (546.1962)

Val Cys Tyr Tyr

C26H34N4O7S (546.2148)

Val Tyr Cys Tyr

C26H34N4O7S (546.2148)

Val Tyr Tyr Cys

C26H34N4O7S (546.2148)

Trp Asn Asn Asn

C23H30N8O8 (546.2186)

Tyr Ala Met Tyr

C26H34N4O7S (546.2148)

Tyr Ala Tyr Met

C26H34N4O7S (546.2148)

Tyr Cys Asp Phe

C25H30N4O8S (546.1784)

Tyr Cys Phe Asp

C25H30N4O8S (546.1784)

Tyr Cys Met Met

C22H34N4O6S3 (546.164)

Tyr Cys Val Tyr

C26H34N4O7S (546.2148)

Tyr Cys Tyr Val

C26H34N4O7S (546.2148)

Tyr Asp Cys Phe

C25H30N4O8S (546.1784)

Tyr Asp Phe Cys

C25H30N4O8S (546.1784)

Tyr Asp Ser Tyr

C25H30N4O10 (546.1962)

Tyr Asp Tyr Ser

C25H30N4O10 (546.1962)

Tyr Phe Cys Asp

C25H30N4O8S (546.1784)

Tyr Phe Asp Cys

C25H30N4O8S (546.1784)

Tyr Phe Met Ser

C26H34N4O7S (546.2148)

Tyr Phe Ser Met

C26H34N4O7S (546.2148)

Tyr His Asn Asn

C23H30N8O8 (546.2186)

Tyr Met Ala Tyr

C26H34N4O7S (546.2148)

Tyr Met Cys Met

C22H34N4O6S3 (546.164)

Tyr Met Phe Ser

C26H34N4O7S (546.2148)

Tyr Met Met Cys

C22H34N4O6S3 (546.164)

Tyr Met Ser Phe

C26H34N4O7S (546.2148)

Tyr Met Tyr Ala

C26H34N4O7S (546.2148)

Tyr Asn His Asn

C23H30N8O8 (546.2186)

Tyr Asn Asn His

C23H30N8O8 (546.2186)

Tyr Ser Asp Tyr

C25H30N4O10 (546.1962)

Tyr Ser Phe Met

C26H34N4O7S (546.2148)

Tyr Ser Met Phe

C26H34N4O7S (546.2148)

Tyr Ser Tyr Asp

C25H30N4O10 (546.1962)

Tyr Val Cys Tyr

C26H34N4O7S (546.2148)

Tyr Val Tyr Cys

C26H34N4O7S (546.2148)

Tyr Tyr Ala Met

C26H34N4O7S (546.2148)

Tyr Tyr Cys Val

C26H34N4O7S (546.2148)

Tyr Tyr Asp Ser

C25H30N4O10 (546.1962)

Tyr Tyr Met Ala

C26H34N4O7S (546.2148)

Tyr Tyr Ser Asp

C25H30N4O10 (546.1962)

Tyr Tyr Val Cys

C26H34N4O7S (546.2148)

Daidzein 4,7-dirhamnoside

C27H30O12 (546.1737)

Guibourtinidol-(4alpha->6)-catechin

C30H26O10 (546.1526)

BX-320

C23H31BrN8O3 (546.1702)

lead cyclohexanebutyrate

C20H34O4Pb (546.2223)

1,4-dibromo-2,5-didecoxybenzene

C26H44Br2O2 (546.1708)

1H-Isoindole-1,3(2H)-dione,5,5-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis[2-methyl-

C33H26N2O6 (546.1791)

9,9-Dioctyl-2,7-Dibromofluorene

C29H40Br2 (546.1497)

2,7-DIBROMO-9,9-BIS(2-ETHYLHEXYL)-9H-FLUORENE

C29H40Br2 (546.1497)

5-DMT-rU

C30H30N2O8 (546.2002)

5'-O-DMT-rU is a modified nucleoside and can be used to synthesize RNA.

9,9-Bis[4-(2-acryloyloxyethyloxy)phenyl]fluorene

C35H30O6 (546.2042)

TRIMETHYL PENTAPHENYL TRISILOXANE

C33H34O2Si3 (546.1867)

Pyromellitic acid di(2-phenyl-2-imidazoline) salt

C28H26N4O8 (546.1751)

Pentaethylene glycol di(p-toluenesulfonate)

C24H34O10S2 (546.1593)

1,3,5-Trimethyl-1,1,3,5,5-pentaphenyltrisiloxane

C33H34O2Si3 (546.1867)

Methyl [(2S)-1-[(2S,5S)-2-[9-chloro-1,11-dihydroisochromeno[4,3:6,7]naphtho[1,2-d]imidazol-2-yl]-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

C30H31ClN4O4 (546.2034)

(4Z)-N-(2-methoxyphenyl)-4-[[2-methoxy-5-(phenylcarbamoyl)phenyl]hydrazinylidene]-3-oxonaphthalene-2-carboxamide

C32H26N4O5 (546.1903)

CHAETOCHROMIN A

C30H26O10 (546.1526)

A biaryl that is 2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione substituted by hydroxy groups at positions 5, 5, 6, 6, 8 and 8 and methyl groups at positions 2, 2, 3 and 3 (the 2R,2S,3R,3S stereoisomer). It has been isolated from Chaetomium gracile.

LY 393558

C26H31FN4O4S2 (546.1771)

2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-6-[[[6-methoxy-4-(trifluoromethyl)[1,1-biphenyl]-2-yl]carbonyl]amino]-, phenyl ester

C31H25F3N2O4 (546.1766)

Tepotinib Hydrochloride Hydrate

C29H31ClN6O3 (546.2146)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D000970 - Antineoplastic Agents

Bistratamide E

C25H34N6O4S2 (546.2083)

A homodetic cyclic peptide that consists of L-threonine and L-valine as the amino acid residues cyclised via amide bonds. It is isolated from Lissoclinum bistratum and exhibits antitumour activity against the human colon tumour cell line.

7-(8-Formyl-1,7-dihydroxy-5-isopropyl-6-methoxy-3-methyl-2-naphthyl)-2,8-dihydroxy-4-isopropyl-3-methoxy-6-methyl-naphthalene-1-carbaldehyde

C32H34O8 (546.2254)

Chaetochromin B

C30H26O10 (546.1526)

A biaryl that is 2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione substituted by hydroxy groups at positions 5, 5, 6, 6, 8 and 8 and methyl groups at positions 2, 2, 3 and 3 (the 2R,2S,3R,3R stereoisomer). It has been isolated from Chaetomium gracile.

Pedunculosumoside D

C27H30O12 (546.1737)

A homoflavonoid glycoside that is 5-prenylophioglonol attached to a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It has been isolated from the whole plants of Ophioglossum pedunculosum.

GMP-N-epsilon-(N-alpha-acetyl lysine methyl ester) 5'-phosphoramidate

C19H29N7O10P (546.1713)

Gmp-n-epsilon-(n-alpha-acetyl lysine methyl ester) 5-phosphoramidate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Gmp-n-epsilon-(n-alpha-acetyl lysine methyl ester) 5-phosphoramidate can be found in a number of food items such as thistle, wax apple, okra, and hedge mustard, which makes gmp-n-epsilon-(n-alpha-acetyl lysine methyl ester) 5-phosphoramidate a potential biomarker for the consumption of these food products. Gmp-n-ε-(n-α-acetyl lysine methyl ester) 5-phosphoramidate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Gmp-n-ε-(n-α-acetyl lysine methyl ester) 5-phosphoramidate can be found in a number of food items such as thistle, wax apple, okra, and hedge mustard, which makes gmp-n-ε-(n-α-acetyl lysine methyl ester) 5-phosphoramidate a potential biomarker for the consumption of these food products.

(1,4)-beta-Xylotetraose

C20H34O17 (546.1796)

GMP-N-epsilon-(N-alpha-acetyl lysine methyl ester) 5-phosphoramidate

C19H29N7O10P- (546.1713)

(1,3)-beta-Xylotetraose

C20H34O17 (546.1796)

PA(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C25H39O11P (546.223)

PA(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0)

C25H39O11P (546.223)

[(5-acetamido-6-methoxy-6-oxohexyl)amino]-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphinate

C19H29N7O10P- (546.1713)

Afzelechin-(4alpha->8)-afzelechin

C30H26O10 (546.1526)

A biflavonoid consisting of two molecules of afzelechin joined by a (4alpha->8) linkage.

1,3,4-trihydroxy-5-[(E)-3-[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoyl]oxycyclohexane-1-carboxylic acid

C27H30O12 (546.1737)

(E)-2-cyano-N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-3-[9-methyl-2-(2-methylphenoxy)-4-oxopyrido[1,2-a]pyrimidin-3-yl]prop-2-enamide

C31H26N6O4 (546.2015)

(2R,2S,3R,3S)-5,5,6,6,8,8-hexahydroxy-2,2,3,3-tetramethyl-2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione

C30H26O10 (546.1526)

(1S)-N-(4-fluorophenyl)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C30H28F2N4O4 (546.2079)

Arabinotetraose

C20H34O17 (546.1796)

1,12-di-L-ascorbyl dodecanedioate

C24H34O14 (546.1948)

(4R,5R)-2-benzoyl-2-[4-(3-hydroxypropoxy)phenyl]-5-phenyl-3-spiro[1,5-dihydro-2-benzazepine-4,4-5H-oxazole]one

C34H30N2O5 (546.2155)

N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C30H30N2O8 (546.2002)

N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C30H30N2O8 (546.2002)

N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C30H30N2O8 (546.2002)

N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C30H30N2O8 (546.2002)

(1R)-N-(2-fluorophenyl)-1-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C30H28F2N4O4 (546.2079)

[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(4-methylphenyl)sulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-(2-pyridinyl)methanone

C29H30N4O5S (546.1937)

(1R)-N-(4-fluorophenyl)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C30H28F2N4O4 (546.2079)

N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C30H30N2O8 (546.2002)

N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C30H30N2O8 (546.2002)

[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(4-methylphenyl)sulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-(2-pyridinyl)methanone

C29H30N4O5S (546.1937)

(1S)-N-(2-fluorophenyl)-1-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C30H28F2N4O4 (546.2079)

Merocyanine 540 anion

C26H32N3O6S2- (546.1732)

beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)-alpha-D-Araf-(1->5)-alpha-D-Araf

C20H34O17 (546.1796)

beta-D-GlcpNAc-(1->4)-alpha-D-Glcp2Ac6SOPr(1-)

C19H32NO15S- (546.1493)

DON-10-gamma-glutamylcysteine

C23H34N2O11S (546.1883)

3,4,5-Trihydroxy-6-[3-hydroxy-2-(7-hydroxy-4-oxo-2,3-dihydrochromen-2-yl)-5-methoxy-4-(3-methylbut-2-enyl)phenoxy]oxane-2-carboxylic acid

C27H30O12 (546.1737)

3,4,5-trihydroxy-6-[[4-hydroxy-6-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-7-methoxy-2,2-dimethyl-3,4-dihydrochromen-5-yl]oxy]oxane-2-carboxylic acid

C27H30O12 (546.1737)

methyl (1R,3S,12S,15S,19S)-18-ethenyl-19-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-20,21-dioxa-4,14-diazahexacyclo[10.8.1.02,17.03,11.03,15.05,10]henicosa-5,7,9-triene-2-carboxylate

C27H34N2O10 (546.2213)

(2S,3R,4S,5R,6R)-6-[[(3R,5R,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,5-dihydroxy-4-sulfooxyoxane-2-carboxylic acid

C25H38O11S (546.2135)

Cymoside-CASMI2016 Category 1-Challenge 5

C27H34N2O10 (546.2213)

methyl (1R,3S,12S,15S,18S,19S)-18-ethenyl-19-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-20,21-dioxa-4,14-diazahexacyclo[10.8.1.02,17.03,11.03,15.05,10]henicosa-5,7,9-triene-2-carboxylate

C27H34N2O10 (546.2213)

methyl (1R,3S,11R,12S,15S,18S,19S)-18-ethenyl-19-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-20,21-dioxa-4,14-diazahexacyclo[10.8.1.02,17.03,11.03,15.05,10]henicosa-5,7,9-triene-2-carboxylate

C27H34N2O10 (546.2213)

alpha-1,5-L-Arabinotetraose

C20H34O17 (546.1796)

ST 18:2;O8;GlcA

C24H34O14 (546.1948)

ST 22:6;O5;GlcA

C28H34O11 (546.2101)

ST 25:3;O8;S

C25H38O11S (546.2135)

4',5,6-trihydroxy-4-(4-hydroxyphenyl)-2-{[(2z)-3-[(2r,3s)-3-methyloxiran-2-yl]prop-2-enoyl]oxy}-[1,1'-biphenyl]-3-yl (2z)-3-[(2r,3s)-3-methyloxiran-2-yl]prop-2-enoate

C30H26O10 (546.1526)

3-methyl-1-[(2r,3s,4r,6r)-3,10,12-trihydroxy-4-(hydroxymethyl)-6-{[2,4,6-trihydroxy-3-(3-methylbutanoyl)phenyl]methyl}-5,7-dioxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-trien-9-yl]butan-1-one

C28H34O11 (546.2101)

(21s)-13,27-dimethoxy-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,7,10,12,14(37),16,18,25,27,30(34),32,35-tridecaene

C34H30N2O5 (546.2155)

(2r,3s)-8-[(2r,3s,4s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(2r,3r)-8-[(2s,4r)-7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

4',5,6-trihydroxy-4-(4-hydroxyphenyl)-2-{[3-(3-methyloxiran-2-yl)prop-2-enoyl]oxy}-[1,1'-biphenyl]-3-yl 3-(3-methyloxiran-2-yl)prop-2-enoate

C30H26O10 (546.1526)

(3s,4s,4as)-7-{2-[(3s)-2,3-dihydroxyindol-3-yl]ethyl}-4-ethenyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,4ah,5h-pyrano[3,4-c]pyridine-6,8-dione

C26H30N2O11 (546.185)

(2r,3s,4s)-2-(3,4-dihydroxyphenyl)-4-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3,4-dihydro-2h-1-benzopyran-3,7-diol

C30H26O10 (546.1526)

(2r,3s)-4-[(6as)-6a-methyl-3-[(1e,3s)-3-methylpent-1-en-1-yl]-6,8-dioxofuro[2,3-h]isochromen-9-yl]-3-methyl-4-oxobutan-2-yl (2r)-2-methoxy-2-phenylacetate

C32H34O8 (546.2254)

4-[(5r,5''r)-5,5''-bis[(1s)-1-hydroxyethyl]-2'-(4-hydroxyphenyl)-5h,5''h-dispiro[furan-2,5'-[4,6,10,12]tetraoxatricyclo[7.3.0.0³,⁷]dodecane-11',2''-furan]-1',3'(7'),8'-trien-8'-yl]phenol

C30H26O10 (546.1526)

methyl (1s,15s,16s,17s,21s)-15-hydroxy-17-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxa-3,13-diazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁶,²¹]docosa-2(10),4,6,8,19-pentaene-20-carboxylate

C27H34N2O10 (546.2213)

methyl (1s,14r,15s,16s,20s)-14-(hydroxymethyl)-16-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate

C27H34N2O10 (546.2213)

(3s)-5-[(3s)-10-hydroxy-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-5-yl]-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-10-ol

C32H34O8 (546.2254)

(2s,3r)-5,6,8-trihydroxy-2,3-dimethyl-9-[(2r,3r)-5,6,8-trihydroxy-2,3-dimethyl-4-oxo-2h,3h-naphtho[2,3-b]pyran-9-yl]-2h,3h-naphtho[2,3-b]pyran-4-one

C30H26O10 (546.1526)

(2r,13s)-16-(2,6-dihydroxy-4-methylbenzoyl)-1,8,10,15,18-pentahydroxy-2,6,17-trimethyl-3-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosa-4,6,8,10,14,16,18-heptaen-12-one

C30H26O10 (546.1526)

1,1',4',5,5',8'-hexahydroxy-3,7-dimethyl-1',2',3',4',5',6',7',8'-octahydro-[2,2'-bianthracene]-9,9',10,10'-tetrone

C30H26O10 (546.1526)

(5r,5''s,6''r)-5-[(1s)-1-hydroxyethyl]-2',8'-bis(4-hydroxyphenyl)-6''-methyl-5'',6''-dihydro-5h-dispiro[furan-2,5'-[4,6,10,12]tetraoxatricyclo[7.3.0.0³,⁷]dodecane-11',2''-pyran]-1',3'(7'),8'-trien-5''-ol

C30H26O10 (546.1526)

(13s,14r)-14-acetyl-7,13,19-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3,5,7,10,15,18(23),19,21-nonaene-9,17-dione

C30H26O10 (546.1526)

[2-isopropyl-3,5-dimethyl-4,6-bis({[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})phenyl](methylsulfanyl)methanone

C25H38O11S (546.2135)

(2s,3s,4s)-2-(4-hydroxyphenyl)-4-[(2r,3r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-8-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(12s,13r)-12-acetyl-9,13,17-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1(15),2(11),3(8),4(22),5,9,16,18(23),20-nonaene-7,19-dione

C30H26O10 (546.1526)

methyl 7-methyl-6-[(5-phenylpenta-2,4-dienoyl)oxy]-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C28H34O11 (546.2101)

10-[(4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl)oxy]-1,3,8,11-tetrahydroxy-9-methoxy-8-methyl-9,10-dihydro-7h-tetracene-5,12-dione

C27H30O12 (546.1737)

(2r,3s)-4-[(6as)-6a-methyl-3-[(1e,3s)-3-methylpent-1-en-1-yl]-6,8-dioxofuro[2,3-h]isochromen-9-yl]-3-methyl-4-oxobutan-2-yl (2s)-2-methoxy-2-phenylacetate

C32H34O8 (546.2254)

(2r,3r)-2-(4-hydroxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(1r,2s,3r)-2-(3,5-dihydroxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)(methoxy)methyl]-2,3-dihydro-1h-indene-4,6-diol

C31H30O9 (546.189)

1,2-dehydroapateline

C34H30N2O5 (546.2155)

{"Ingredient_id": "HBIN000777","Ingredient_name": "1,2-dehydroapateline","Alias": "NA","Ingredient_formula": "C34H30N2O5","Ingredient_Smile": "CN1CCC2=CC(=C3C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7=NCCC8=CC(=C(O4)C=C87)O3)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4876","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3',4',7-trihydroxyflavan(4→8)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4r)-form

C30H26O10 (546.1526)

{"Ingredient_id": "HBIN007318","Ingredient_name": "3',4',7-trihydroxyflavan(4\u21928)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4r)-form","Alias": "NA","Ingredient_formula": "C30H26O10","Ingredient_Smile": "NA","Ingredient_weight": "546.52","OB_score": "NA","CAS_id": "162753-74-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8302","PubChem_id": "NA","DrugBank_id": "NA"}

3',4',7-trihydroxyflavan(4→8)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4s)-form

C30H26O10 (546.1526)

{"Ingredient_id": "HBIN007319","Ingredient_name": "3',4',7-trihydroxyflavan(4\u21928)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4s)-form","Alias": "NA","Ingredient_formula": "C30H26O10","Ingredient_Smile": "NA","Ingredient_weight": "546.52","OB_score": "NA","CAS_id": "162869-46-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8301","PubChem_id": "NA","DrugBank_id": "NA"}

3α-dihydrocadambine

C27H34N2O10 (546.2213)

{"Ingredient_id": "HBIN007940","Ingredient_name": "3\u03b1-dihydrocadambine","Alias": "3alpha-dihydrocadambine","Ingredient_formula": "C27H34N2O10","Ingredient_Smile": "COC(=O)C1=COC(C2C1CC3C4=C(CCN3CC2O)C5=CC=CC=C5N4)OC6C(C(C(C(O6)CO)O)O)O","Ingredient_weight": "546.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15059;SMIT18381","TCMID_id": "23513;5549","TCMSP_id": "NA","TCM_ID_id": "8185","PubChem_id": "162138","DrugBank_id": "NA"}

3-beta-isodihydrocadambine

C27H34N2O10 (546.2213)

{"Ingredient_id": "HBIN008273","Ingredient_name": "3-beta-isodihydrocadambine","Alias": "3beta-isodihydrocadambine; 3\u03b2-isodihydrocadambine","Ingredient_formula": "C27H34N2O10","Ingredient_Smile": "COC(=O)C1=COC(C2C1CC3C4=C(CCN3C2CO)C5=CC=CC=C5N4)OC6C(C(C(C(O6)CO)O)O)O","Ingredient_weight": "546.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT18369;SMIT16026","TCMID_id": "23461;31346;11374","TCMSP_id": "NA","TCM_ID_id": "8174","PubChem_id": "188431","DrugBank_id": "NA"}

4'-demethyldesoxypodophyllotoxin-4-o-β-d-glucoside

C27H30O12 (546.1737)

{"Ingredient_id": "HBIN010314","Ingredient_name": "4'-demethyldesoxypodophyllotoxin-4-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C27H30O12","Ingredient_Smile": "COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C3C4C(CC5=CC6=C(C=C35)OCO6)COC4=O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5074","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

afzelechin-(4α→8)-afzelechin

C30H26O10 (546.1526)

{"Ingredient_id": "HBIN014789","Ingredient_name": "afzelechin-(4\u03b1\u21928)-afzelechin","Alias": "NA","Ingredient_formula": "C30H26O10","Ingredient_Smile": "C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC=C(C=C5)O)O)O)O)C6=CC=C(C=C6)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "678","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

4-[6-(3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-2-yl)-2,3-dihydroxyphenyl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C30H26O10 (546.1526)

{2-isopropyl-3,5-dimethyl-4,6-bis[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}(methylsulfanyl)methanone

C25H38O11S (546.2135)

(2r,3r)-8-[(2s,4s)-7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(2r,3s)-5,6,8-trihydroxy-2,3-dimethyl-9-[(2r,3r)-5,6,8-trihydroxy-2,3-dimethyl-4-oxo-2h,3h-naphtho[2,3-b]pyran-9-yl]-2h,3h-naphtho[2,3-b]pyran-4-one

C30H26O10 (546.1526)

methyl (1s,14r,15s,16s,20s)-14-(hydroxymethyl)-16-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate

C27H34N2O10 (546.2213)

2-(3,4-dihydroxyphenyl)-8-[2-(3,4-dihydroxyphenyl)-7-hydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

16-(2,6-dihydroxy-4-methylbenzoyl)-1,8,10,15,18-pentahydroxy-2,6,17-trimethyl-3-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosa-4,6,8,10,14,16,18-heptaen-12-one

C30H26O10 (546.1526)

4',5,6-trihydroxy-4-(4-hydroxyphenyl)-2-{[(2z)-3-[(2s,3s)-3-methyloxiran-2-yl]prop-2-enoyl]oxy}-[1,1'-biphenyl]-3-yl (2z)-3-[(2r,3r)-3-methyloxiran-2-yl]prop-2-enoate

C30H26O10 (546.1526)

(1s,2r,6r,7r,10s,11r,16r,18r,19s,20s)-6-(furan-3-yl)-2,19,20-trihydroxy-7,17,17-trimethyl-4,14-dioxo-5,13,21-trioxahexacyclo[17.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶.0¹¹,²⁰]docosan-18-yl acetate

C28H34O11 (546.2101)

methyl 15-hydroxy-17-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxa-3,13-diazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁶,²¹]docosa-2(10),4,6,8,19-pentaene-20-carboxylate

C27H34N2O10 (546.2213)

2,2',4,4',7,7',10,10'-octahydroxy-7,7'-dimethyl-6h,6'h,8h,8'h-[1,1'-bianthracene]-5,5'-dione

C30H26O10 (546.1526)

(2r,3s,4s)-4-{6-[(2s,3s)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-2-yl]-2,3-dihydroxyphenyl}-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C30H26O10 (546.1526)

methyl 3-[(3,4-dimethylpent-2-enoyl)oxy]-11,15,16-trihydroxy-9,13-dimethyl-4,10-dioxo-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadeca-8,11-diene-17-carboxylate

C28H34O11 (546.2101)

methyl (1r,14r,15s,16s,20s)-14-(hydroxymethyl)-16-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate

C27H34N2O10 (546.2213)

(2r,3r)-2-(3,4-dihydroxyphenyl)-8-[(2s,4s)-2-(3,4-dihydroxyphenyl)-7-hydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(1s,2r,4s,5r,6s,7r,9r,12r)-4,5,12-tris(acetyloxy)-6-(hydroxymethyl)-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C28H34O11 (546.2101)

1,8-bis[(4-hydroxyphenyl)methyl]-7-methoxy-3-phenyl-9,10-dihydrophenanthrene-2,4,5-triol

C35H30O6 (546.2042)

2-(3,4-dihydroxyphenyl)-4-[2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3,4-dihydro-2h-1-benzopyran-3,7-diol

C30H26O10 (546.1526)

afzelechin-(4α->8)-afzelechin

C30H26O10 (546.1526)

(4s,7r,8s,11s,18s)-4,11,18-triisopropyl-7-methyl-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),9,12(23),14,16,19(22)-octaene-2,9,16-triol

C25H34N6O4S2 (546.2083)

(12r,13s)-12-acetyl-9,13,17-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1(15),2(11),3(8),4(22),5,9,16,18(23),20-nonaene-7,19-dione

C30H26O10 (546.1526)

(2r,3s)-8-[(2s,4r)-7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(2r,3s,4s)-4-{6-[(2r,3s)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-2-yl]-2,3-dihydroxyphenyl}-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C30H26O10 (546.1526)

7-(5-hydroxy-2-oxo-5h-furan-3-yl)-1,8,12,17,17-pentamethyl-5,15,20-trioxo-3,6,16-trioxapentacyclo[9.9.0.0²,⁴.0²,⁸.0¹²,¹⁸]icosan-13-yl acetate

C28H34O11 (546.2101)

5-acetyl-8,23-dihydroxy-7,12,19,24-tetramethoxy-3-methyl-4-oxaheptacyclo[14.8.0.0¹,⁵.0⁶,¹⁵.0⁹,¹⁴.0¹³,¹⁸.0¹⁷,²²]tetracosa-6,8,11,13,15,17,19,22-octaene-10,21-dione

C30H26O10 (546.1526)

(1r,2s,21s,23s)-2-acetyl-5,20-dihydroxy-4,9,16,21-tetramethoxy-23-methyl-22-oxaheptacyclo[11.11.0.0¹,²¹.0³,¹².0⁶,¹¹.0¹⁰,¹⁵.0¹⁴,¹⁹]tetracosa-3,5,8,10,12,14,16,19-octaene-7,18-dione

C30H26O10 (546.1526)

(21s)-27-methoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,7,10,12,14(37),16,18,25(33),26,28(32),30(34),35-tridecaen-13-ol

C34H30N2O5 (546.2155)

(2r,3s,4r)-2-(3,4-dihydroxyphenyl)-4-[(2s,3s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3,4-dihydro-2h-1-benzopyran-3,7-diol

C30H26O10 (546.1526)

methyl (1s,4as,6s,7s,7as)-7-methyl-6-{[(2e,4e)-5-phenylpenta-2,4-dienoyl]oxy}-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C28H34O11 (546.2101)

(5s,5's,10ar,10'ar)-1,1',5,5',9,9'-hexahydroxy-3,3',10a,10'a-tetramethyl-5h,5'h-[2,2'-bixanthene]-8,8'-dione

C30H26O10 (546.1526)

(1r,2r)-3-(acetyloxy)-1-[4-(acetyloxy)-3-methoxyphenyl]-2-{4-[3-(acetyloxy)propyl]-2-methoxyphenoxy}propyl acetate

C28H34O11 (546.2101)

1-(3-{1-hydroxy-2,2-dimethyl-3,5'-dioxo-9ah-spiro[imidazo[1,2-a]indole-9,2'-oxolan]-4'-yl}-4-oxoquinazolin-2-yl)-2-methylpropyl acetate

C29H30N4O7 (546.2114)

(3s,4s,4as)-7-{2-[(3r)-2,3-dihydroxyindol-3-yl]ethyl}-4-ethenyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,4ah,5h-pyrano[3,4-c]pyridine-6,8-dione

C26H30N2O11 (546.185)

6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-3-(1-{6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}-2-methylpropyl)-4-hydroxypyran-2-one

C30H26O10 (546.1526)

(2r,3r)-5,6,8-trihydroxy-2,3-dimethyl-9-[(2r,3r)-5,6,8-trihydroxy-2,3-dimethyl-4-oxo-2h,3h-naphtho[2,3-b]pyran-9-yl]-2h,3h-naphtho[2,3-b]pyran-4-one

C30H26O10 (546.1526)

2-phenyl-7-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]chromen-4-one

C27H30O12 (546.1737)

methyl 15-hydroxy-17-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxa-3,13-diazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁶,²¹]docosa-2(10),4,6,8,19-pentaene-20-carboxylate

C27H34N2O10 (546.2213)

6-{9,10-dihydroxy-7-methoxy-3-methyl-1-oxo-3h,4h-naphtho[2,3-c]pyran-6-yl}-9,10-dihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1-one

C30H26O10 (546.1526)

(1r,2s,5s,8s,9r,14r,15r,17r,18r,21s,24r,26s,27s)-5,14,15-trihydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.1¹⁸,²⁷.0¹,⁵.0²,²⁴.0⁸,¹⁷.0⁹,¹⁴.0²¹,²⁶]nonacosane-4,10,22,29-tetrone

C28H34O11 (546.2101)

4,5-dihydroxy-6-[(3-phenylprop-2-en-1-yl)oxy]-2-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-3-yl benzoate

C28H34O11 (546.2101)

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-5-hydroxy-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C28H34O11 (546.2101)

methyl (1s,15s,16s,17s,21s)-15-hydroxy-17-{[(2s,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxa-3,13-diazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁶,²¹]docosa-2(10),4,6,8,19-pentaene-20-carboxylate

C27H34N2O10 (546.2213)

(3s,4r,4as)-7-{2-[(3r)-2,3-dihydroxyindol-3-yl]ethyl}-4-ethenyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,4ah,5h-pyrano[3,4-c]pyridine-6,8-dione

C26H30N2O11 (546.185)

2-acetyl-5,20-dihydroxy-4,9,16,21-tetramethoxy-23-methyl-22-oxaheptacyclo[11.11.0.0¹,²¹.0³,¹².0⁶,¹¹.0¹⁰,¹⁵.0¹⁴,¹⁹]tetracosa-3,5,8,10,12,14,16,19-octaene-7,18-dione

C30H26O10 (546.1526)

(1r,6s,11s,16s,19r)-6-(furan-3-yl)-2,19,20-trihydroxy-7,17,17-trimethyl-4,14-dioxo-5,13,21-trioxahexacyclo[17.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶.0¹¹,²⁰]docosan-18-yl acetate

C28H34O11 (546.2101)

8-[2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

5-(1-hydroxyethyl)-2',8'-bis(4-hydroxyphenyl)-6''-methyl-5'',6''-dihydro-5h-dispiro[furan-2,5'-[4,6,10,12]tetraoxatricyclo[7.3.0.0³,⁷]dodecane-11',2''-pyran]-1',3'(7'),8'-trien-5''-ol

C30H26O10 (546.1526)

8-{9,10-dihydroxy-7-methoxy-3-methyl-1-oxo-3h,4h-naphtho[2,3-c]pyran-8-yl}-9,10-dihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1-one

C30H26O10 (546.1526)

4,24-dimethyl 11-(1-hydroxyethyl)-16-methyl-1,6,13,22-tetraazaheptacyclo[15.11.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0²¹,²⁹.0²³,²⁸]nonacosa-2,4,6,8,10,12,14,17(29),18,20,23(28),24,26-tridecaene-4,24-dicarboxylate

C32H26N4O5 (546.1903)

10-(3,5-dimethoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one

C27H30O12 (546.1737)

(5s,5''s,6r,6''r)-2',8'-bis(4-hydroxyphenyl)-6,6''-dimethyl-5,5'',6,6''-tetrahydrodispiro[pyran-2,5'-[4,6,10,12]tetraoxatricyclo[7.3.0.0³,⁷]dodecane-11',2''-pyran]-1',3'(7'),8'-triene-5,5''-diol

C30H26O10 (546.1526)

(1r)-1-{3-[(4'r,9s,9as)-1-hydroxy-2,2-dimethyl-3,5'-dioxo-9ah-spiro[imidazo[1,2-a]indole-9,2'-oxolan]-4'-yl]-4-oxoquinazolin-2-yl}-2-methylpropyl acetate

C29H30N4O7 (546.2114)

(1'r,2's,4's,5'r,8'r)-1,1',4',5,5',8'-hexahydroxy-3,7-dimethyl-1',2',3',4',5',6',7',8'-octahydro-[2,2'-bianthracene]-9,9',10,10'-tetrone

C30H26O10 (546.1526)

(10r,11r,15r)-10-(3,5-dimethoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one

C27H30O12 (546.1737)

(1r,3s,5r,24s)-5-acetyl-8,23-dihydroxy-7,12,19,24-tetramethoxy-3-methyl-4-oxaheptacyclo[14.8.0.0¹,⁵.0⁶,¹⁵.0⁹,¹⁴.0¹³,¹⁸.0¹⁷,²²]tetracosa-6,8,11,13,15,17,19,22-octaene-10,21-dione

C30H26O10 (546.1526)

4,5,12-tris(acetyloxy)-6-(hydroxymethyl)-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C28H34O11 (546.2101)

methyl 14-(hydroxymethyl)-16-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate

C27H34N2O10 (546.2213)

methyl (1r,2s,3r,6r,13s,14r,15r,16s,17s)-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-11,15,16-trihydroxy-9,13-dimethyl-4,10-dioxo-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadeca-8,11-diene-17-carboxylate

C28H34O11 (546.2101)

16-acetyl-12,13,17-trihydroxy-7,9,14,20-tetramethoxy-17-methylhexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3,6,8,10,12,14,18(23),19-nonaene-5,21-dione

C30H26O10 (546.1526)

(2r,3s,4r)-2-(3,4-dihydroxyphenyl)-4-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3,4-dihydro-2h-1-benzopyran-3,7-diol

C30H26O10 (546.1526)

(1s,2s,5s,6s,7s,9r,12r)-7,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate

C28H34O11 (546.2101)

methyl (1s,4ar,6r,7r,7ar)-6-hydroxy-7-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C27H34N2O10 (546.2213)

10-acetyl-9,14,21-trihydroxy-6,12,17,19-tetramethoxy-9-methylhexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),6,11,14,16,18(23),19,21-nonaene-5,13-dione

C30H26O10 (546.1526)

2',8'-bis(4-hydroxyphenyl)-6,6''-dimethyl-5,5'',6,6''-tetrahydrodispiro[pyran-2,5'-[4,6,10,12]tetraoxatricyclo[7.3.0.0³,⁷]dodecane-11',2''-pyran]-1',3'(7'),8'-triene-5,5''-diol

C30H26O10 (546.1526)

(2s,3s)-5,6,8-trihydroxy-2,3-dimethyl-9-[(2s,3s)-5,6,8-trihydroxy-2,3-dimethyl-4-oxo-2h,3h-naphtho[2,3-b]pyran-9-yl]-2h,3h-naphtho[2,3-b]pyran-4-one

C30H26O10 (546.1526)

(12s,13r)-9-hydroxy-13-[(1r)-1-hydroxyethyl]-12-[(1s)-1-hydroxyethyl]-5,10,23-trimethoxy-16,18-dioxaheptacyclo[12.11.0.0²,¹¹.0³,⁸.0⁴,²⁴.0¹⁵,¹⁹.0²⁰,²⁵]pentacosa-1(14),2(11),3(8),4(24),5,9,15(19),20(25),22-nonaene-7,21-dione

C30H26O10 (546.1526)

(3r)-3,5,10-trihydroxy-3-methyl-9-[(2r,5s,6r)-6-methyl-5-[(2r,6s)-6-methyl-5-oxo-2,6-dihydropyran-2-yl]oxan-2-yl]-2,4-dihydrotetracene-1,6,11-trione

C31H30O9 (546.189)

methyl (1s,15r,16s,17r,21s)-15-hydroxy-17-{[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}-18-oxa-3,13-diazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁶,²¹]docosa-2(10),4,6,8,19-pentaene-20-carboxylate

C27H34N2O10 (546.2213)

methyl 6-hydroxy-7-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C27H34N2O10 (546.2213)

2-{[6-({4,5-dihydroxy-6-[(4,5,6-trihydroxyoxan-3-yl)oxy]oxan-3-yl}oxy)-4,5-dihydroxyoxan-3-yl]oxy}oxane-3,4,5-triol

C20H34O17 (546.1796)

(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-{[(2e)-3-phenylprop-2-en-1-yl]oxy}-2-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-3-yl benzoate

C28H34O11 (546.2101)

(2s,3s)-6-[(2s,3r,4r)-3,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(3r)-6-[(3r)-9,10-dihydroxy-7-methoxy-3-methyl-1-oxo-3h,4h-naphtho[2,3-c]pyran-6-yl]-9,10-dihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1-one

C30H26O10 (546.1526)

2-(4-hydroxyphenyl)-8-[3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(3e)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-1,3-benzodioxol-5-yl)methylidene]oxolan-2-one

C27H30O12 (546.1737)

(2r,3r)-8-[(2s,3r,4r)-3,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(1r,2s,3r)-2-(3,5-dihydroxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-1-[(r)-(4-hydroxy-3-methoxyphenyl)(methoxy)methyl]-2,3-dihydro-1h-indene-4,6-diol

C31H30O9 (546.189)

8-[7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

4,11,18-triisopropyl-7-methyl-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),9,12(23),14,16,19(22)-octaene-2,9,16-triol

C25H34N6O4S2 (546.2083)

6-[2-(3,4-dihydroxyphenyl)ethenyl]-3-(1-{6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}-2-methylpropyl)-4-hydroxypyran-2-one

C30H26O10 (546.1526)

(2s,3r,4s,5s,6r)-2-{[4-(2h-1,3-benzodioxol-5-yl)-2,3-bis(hydroxymethyl)-6,7-dimethoxynaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C27H30O12 (546.1737)

1,1',5,5',9,9'-hexahydroxy-3,3',10a,10'a-tetramethyl-5h,5'h-[2,2'-bixanthene]-8,8'-dione

C30H26O10 (546.1526)

(2r,3s)-2-(3,4-dihydroxyphenyl)-8-[(2s,4r)-2-(3,4-dihydroxyphenyl)-7-hydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

7-[2-(2,3-dihydroxyindol-3-yl)ethyl]-4-ethenyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,4ah,5h-pyrano[3,4-c]pyridine-6,8-dione

C26H30N2O11 (546.185)

2-(3,5-dihydroxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)(methoxy)methyl]-2,3-dihydro-1h-indene-4,6-diol

C31H30O9 (546.189)

14-acetyl-7,13,19-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3,5,7,10,15,18(23),19,21-nonaene-9,17-dione

C30H26O10 (546.1526)

(1r,2s,6s,7s,10r,11s,16s,18s,19r,20r)-6-(furan-3-yl)-2,19,20-trihydroxy-7,17,17-trimethyl-4,14-dioxo-5,13,21-trioxahexacyclo[17.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶.0¹¹,²⁰]docosan-18-yl acetate

C28H34O11 (546.2101)

27-methoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,7,10,12,14(37),16,18,25(33),26,28(32),30(34),35-tridecaen-13-ol

C34H30N2O5 (546.2155)

(2r,3r)-8-[(2r,3r,4r)-3,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

6-(furan-3-yl)-2,19,20-trihydroxy-7,17,17-trimethyl-4,14-dioxo-5,13,21-trioxahexacyclo[17.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶.0¹¹,²⁰]docosan-18-yl acetate

C28H34O11 (546.2101)

(3e,4r)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-1,3-benzodioxol-5-yl)methylidene]oxolan-2-one

C27H30O12 (546.1737)

4',5,6-trihydroxy-4-(4-hydroxyphenyl)-2-{[(2z)-3-[(2s,3s)-3-methyloxiran-2-yl]prop-2-enoyl]oxy}-[1,1'-biphenyl]-3-yl (2z)-3-[(2s,3s)-3-methyloxiran-2-yl]prop-2-enoate

C30H26O10 (546.1526)

(2r,3r,4s)-4-{[(2s,3r,4r,5r)-5-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxyoxan-2-yl]oxy}-2,3,5-trihydroxypentanal

C20H34O17 (546.1796)

methyl (1r,15s,16s,17s,21s)-15-hydroxy-17-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxa-3,13-diazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁶,²¹]docosa-2(10),4,6,8,19-pentaene-20-carboxylate

C27H34N2O10 (546.2213)

8-[3,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

2-phenyl-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}chromen-4-one

C27H30O12 (546.1737)

13,27-dimethoxy-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,7,10,12,14(37),16,18,25,27,30(34),32,35-tridecaene

C34H30N2O5 (546.2155)

5,14,15-trihydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.1¹⁸,²⁷.0¹,⁵.0²,²⁴.0⁸,¹⁷.0⁹,¹⁴.0²¹,²⁶]nonacosane-4,10,22,29-tetrone

C28H34O11 (546.2101)

(2s,3s)-5,6,8-trihydroxy-2,3-dimethyl-9-[(2r,3r)-5,6,8-trihydroxy-2,3-dimethyl-4-oxo-2h,3h-naphtho[2,3-b]pyran-9-yl]-2h,3h-naphtho[2,3-b]pyran-4-one

C30H26O10 (546.1526)

methyl (1s,15s,16s,17s,21s)-15-hydroxy-17-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxa-3,13-diazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁶,²¹]docosa-2(10),4,6,8,19-pentaene-20-carboxylate

C27H34N2O10 (546.2213)

7,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate

C28H34O11 (546.2101)

(3s,4r,4as)-7-{2-[(3s)-2,3-dihydroxyindol-3-yl]ethyl}-4-ethenyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,4ah,5h-pyrano[3,4-c]pyridine-6,8-dione

C26H30N2O11 (546.185)

(1r)-1-{3-[(4's,9r,9ar)-1-hydroxy-2,2-dimethyl-3,5'-dioxo-9ah-spiro[imidazo[1,2-a]indole-9,2'-oxolan]-4'-yl]-4-oxoquinazolin-2-yl}-2-methylpropyl acetate

C29H30N4O7 (546.2114)

methyl 15-hydroxy-17-[(3,4,5,6-tetrahydroxyoxan-2-yl)methoxy]-18-oxa-3,13-diazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁶,²¹]docosa-2(10),4,6,8,19-pentaene-20-carboxylate

C27H34N2O10 (546.2213)

(2s,3r,4s,5r)-2-{[(3r,4r,5r,6s)-6-{[(3r,4r,5r,6s)-4,5-dihydroxy-6-{[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxyoxan-3-yl]oxy}oxane-3,4,5-triol

C20H34O17 (546.1796)

vioxanthin

C30H26O10 (546.1526)

(1r,2s,5s,8s,9r,14r,15r,17r,21s,24r,26s,27s)-5,14,15-trihydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.1¹⁸,²⁷.0¹,⁵.0²,²⁴.0⁸,¹⁷.0⁹,¹⁴.0²¹,²⁶]nonacosane-4,10,22,29-tetrone

C28H34O11 (546.2101)

(2r,3r)-2-(3,4-dihydroxyphenyl)-8-[(2s,4r)-2-(3,4-dihydroxyphenyl)-7-hydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

3-(acetyloxy)-1-[4-(acetyloxy)-3-methoxyphenyl]-2-{4-[3-(acetyloxy)propyl]-2-methoxyphenoxy}propyl acetate

C28H34O11 (546.2101)

(2r,3s,4s)-2-(3,4-dihydroxyphenyl)-4-[(2s,3s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3,4-dihydro-2h-1-benzopyran-3,7-diol

C30H26O10 (546.1526)

(2r,3s)-2-(3,4-dihydroxyphenyl)-8-[(2s,4s)-2-(3,4-dihydroxyphenyl)-7-hydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(1r,2r,4s,7r,8s,11r,12r,13s,18r)-7-[(5s)-5-hydroxy-2-oxo-5h-furan-3-yl]-1,8,12,17,17-pentamethyl-5,15,20-trioxo-3,6,16-trioxapentacyclo[9.9.0.0²,⁴.0²,⁸.0¹²,¹⁸]icosan-13-yl acetate

C28H34O11 (546.2101)

4,24-dimethyl (16r)-11-[(1r)-1-hydroxyethyl]-16-methyl-1,6,13,22-tetraazaheptacyclo[15.11.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0²¹,²⁹.0²³,²⁸]nonacosa-2,4,6,8,10,12,14,17(29),18,20,23(28),24,26-tridecaene-4,24-dicarboxylate

C32H26N4O5 (546.1903)

[8-acetyl-3-(benzoyloxy)-11,12-dihydroxy-13-(methoxycarbonyl)-9-methyl-4-oxo-5,14-dioxatetracyclo[8.5.0.0¹,⁶.0²,¹³]pentadecan-9-yl]acetic acid

C27H30O12 (546.1737)

6-[7,8-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,4,7,8-tetrol

C30H26O10 (546.1526)

(2r,3r,4r)-6-[(2s,4s)-7,8-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,4,7,8-tetrol

C30H26O10 (546.1526)

(2r,3r)-8-[(2r,3s,4r)-3,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(7r,7'r)-2,2',4,4',7,7',10,10'-octahydroxy-7,7'-dimethyl-6h,6'h,8h,8'h-[1,1'-bianthracene]-5,5'-dione

C30H26O10 (546.1526)

(1s,2r,4s,5r,6s,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-5-hydroxy-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C28H34O11 (546.2101)

4-{[5-({3,4-dihydroxy-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-3,4-dihydroxyoxan-2-yl]oxy}-2,3,5-trihydroxypentanal

C20H34O17 (546.1796)

(2r,3s)-8-[(2r,3s,4s)-3,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O10 (546.1526)

(1r,2r,4s,7r,8s,11r,12r,13r,18r)-7-[(5s)-5-hydroxy-2-oxo-5h-furan-3-yl]-1,8,12,17,17-pentamethyl-5,15,20-trioxo-3,6,16-trioxapentacyclo[9.9.0.0²,⁴.0²,⁸.0¹²,¹⁸]icosan-13-yl acetate

C28H34O11 (546.2101)

4-[5,5''-bis(1-hydroxyethyl)-2'-(4-hydroxyphenyl)-5h,5''h-dispiro[furan-2,5'-[4,6,10,12]tetraoxatricyclo[7.3.0.0³,⁷]dodecane-11',2''-furan]-1',3'(7'),8'-trien-8'-yl]phenol

C30H26O10 (546.1526)

methyl (1r,14r,15s,16s,20s)-14-(hydroxymethyl)-16-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate

C27H34N2O10 (546.2213)

7-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)chromen-4-one

C27H30O12 (546.1737)